The Form 4 filing, a report of insider stock trades, was filed on Nov. 10, 2026. It covers Nov. 6 trades by Jonathan Sheena, a director and co-founder of Natera (NTRA).
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-06 |
| Date of Latest Transaction | 2026-11-06 |
| Buy/Sell | sell |
| Transaction Count | 18 |
| Shares Transacted | 3,086 |
| Price | $316.14 |
| Total Transaction Value | $975,623.46 |
| Insider | |
| Ticker Symbol | NTRA |
| Company | Natera, Inc. |
| Insider Name | Sheena Jonathan |
| Insider Title | Director, Other, CO-FOUNDER |
| Sector - Industry | Healthcare - Diagnostics & Research |
| Holdings | |
| Total Shares Owned After Transaction | 214,462 |
| Position Size Change | 1.42% |
| Filing | |
| Filing Date | 2026-11-10 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
These were stock sales, reported under transaction code S. The filing information lists 18 sale transactions, all dated Nov. 6, 2026.
What was the average price of the transaction?
The average sale price was $316.14 per share across the 18 transactions. Prices for each separate sale were not available.
How did this transaction affect the insider's holdings?
Jonathan Sheena sold 3,086 shares and reported owning 214,462 shares afterward. The shares sold made up 1.42% of his reported shares before the sale.
What's the total transaction value?
The total value of the 18 sales was $975,623.46, rounded to the nearest cent. This is the value for all 3,086 shares sold.
Are there any special circumstances around this transaction?
The filing information indicates a reference to a Rule 10b5-1 trading plan. These plans set instructions for trades in advance. The available details do not show which of the 18 sales that reference covers. Footnote text was not available to check the plan's terms, when it began, or its trading schedule. The reference alone does not confirm that the sales met all of the rule's requirements.
For research purposes only; not investment advice.